There are 749 resources available
Precision medicine and ESMO Scale for Clinical Actionability of molecular Target (ESCAT) biomarkers
Presenter: Fabrice André
Session: ESMO – CSCO Collaborative Session: Drug prioritisation and support of biomarkers
Resources:
Slides
Webcast
Development of biomarker driven clinical studies in China
Presenter: Xiaotian Zhang
Session: ESMO – CSCO Collaborative Session: Drug prioritisation and support of biomarkers
Resources:
Slides
Webcast
Phase III KEYNOTE-048 study of first-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma: Asia vs non-Asia subgroup analysis
Presenter: Nuttapong Ngamphaiboon
Session: Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
Resources:
Slides
Webcast
Development and validation of a risk model integrating plasma Epstein-Barr virus DNA (EBV DNA) level and TNM stage for stratification of nasopharyngeal cancer (NPC) to adjuvant therapy
Presenter: Edwin Hui
Session: Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
Resources:
Slides
Webcast
420O - Role of cardioprotective therapies for prevention of cardiotoxicity in breast cancer: A systematic review and meta-analysis
Presenter: Yek Ching Kong
Session: Mini Oral session - Supportive and palliative care
Resources:
Abstract
351O - The FAFA (FAn on FAce) trial: A randomized clinical trial on the effect of a fan blowing air on the face to relieve dyspnea in Filipino patients with terminal cancer
Presenter: Frederic Ivan Ting
Session: Mini Oral session - Supportive and palliative care
Resources:
Abstract
352O - Parenting experiences of cancer patients with minor children and their conversations about the possibility of death: A cross-sectional web-based survey for the online cancer community
Presenter: Yuko Usui
Session: Mini Oral session - Supportive and palliative care
Resources:
Abstract
422O - Needs of cancer patients in an Asian setting
Presenter: Nirmala Bhoo-Pathy
Session: Mini Oral session - Supportive and palliative care
Resources:
Abstract
How to manage toxicity of immunotherapy
Presenter: John Haanen
Session: How to manage toxicity of immunotherapy
Resources:
Slides
Webcast
To use or not to use: Genomics assays in guiding adjuvant treatment of HR positive breast cancer
Presenter: Fatima Cardoso
Session: To use or not to use: Genomics assays in guiding adjuvant treatment of HR positive breast cancer
Resources:
Slides
Webcast